Upregulation of low-density lipoprotein receptor activity in steroid-resistant nephrotic syndrome treated with low-density lipoprotein apheresis: Clinical efficacy and potential mechanism

被引：0
|
作者：
Shima, Hisato [1 ,2 ]
机构：
[1] Kawashima Hosp, Dept Kidney Dis, Tokushima, Japan
[2] Kawashima Hosp, Dept Kidney Dis, 6-1 Kitasakoichiban cho, Tokushima 7700011, Japan
来源：
THERAPEUTIC APHERESIS AND DIALYSIS | 2024年 / 28卷 / 04期
关键词：
APOLIPOPROTEIN;
D O I：
10.1111/1744-9987.14115
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：516 / 517
页数：2
相关论文
共 50 条
  • [1] Low-density Lipoprotein Receptor Activities, Lipids, Apolipoprotein, and Clinical Course of Patients with Steroid-resistant Nephrotic Syndrome Treated with Low density Lipoprotein Apheresis: A Case Series
    Shima, Hisato
    Higashiguchi, Yusuke
    Doi, Toshio
    Harada, Megumi
    Okamoto, Takuya
    Inoue, Tomoko
    Tashiro, Manabu
    Okada, Kazuyoshi
    Minakuchi, Jun
    INTERNAL MEDICINE, 2024, 63 (03) : 433 - 438
  • [2] Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome
    Muso, E
    Mune, M
    Fujii, Y
    Imai, E
    Ueda, N
    Hatta, K
    Imada, A
    Miki, S
    Kuwahara, T
    Takamitsu, Y
    Takemura, T
    Tsubakihara, Y
    KIDNEY INTERNATIONAL, 1999, 56 : S122 - S125
  • [3] Rapid normalization of interleukin-8 production after low-density lipoprotein apheresis in steroid-resistant nephrotic syndrome
    Sakurai, M
    Muso, E
    Matushima, H
    Ono, T
    Sasayama, S
    KIDNEY INTERNATIONAL, 1999, 56 : S210 - S212
  • [4] Proteomics Approach Identifies Factors Associated With the Response to Low-Density Lipoprotein Apheresis Therapy in Patients With Steroid-Resistant Nephrotic Syndrome
    Kuribayashi-Okuma, Emiko
    Shibata, Shigeru
    Arai, Shigeyuki
    Ota, Tatsuru
    Watanabe, Sumiyo
    Hisaki, Harumi
    Okazaki, Tomoki
    Toda, Tosifusa
    Uchida, Shunya
    THERAPEUTIC APHERESIS AND DIALYSIS, 2016, 20 (02) : 174 - 182
  • [5] Remission of a refractory nephrotic syndrome by low-density lipoprotein apheresis.
    Faucher, C
    Albert, C
    Beaufils, H
    Dupouet, L
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0433 - A0433
  • [6] Evaluation of efficacy of low-density lipoprotein apheresis to improve diabetic nephrotic syndrome.
    Yunoki, O
    Yasumoto, Y
    Miyashita, H
    Homan, H
    Haruta, T
    Ueda, T
    Uchida, Y
    Yoshidome, E
    Ikeda, T
    Arima, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0607 - A0607
  • [7] LOW-DENSITY LIPOPROTEIN METABOLISM IN THE NEPHROTIC SYNDROME
    WARWICK, GL
    CASLAKE, MJ
    BOULTONJONES, JM
    DAGEN, M
    PACKARD, CJ
    SHEPHERD, J
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (02): : 187 - 192
  • [8] Rituximab-Resistant Nephrotic Syndrome With Successful Induction of Remission by Low-Density Lipoprotein Apheresis
    Suzuki, Hiroyuki
    Tsukamoto, Tatsuo
    Muso, Eri
    THERAPEUTIC APHERESIS AND DIALYSIS, 2017, 21 (03) : 295 - 296
  • [9] Low-density lipoprotein apheresis: An overview
    Bambauer, R
    Schiel, R
    Latza, R
    THERAPEUTIC APHERESIS AND DIALYSIS, 2003, 7 (04) : 382 - 390
  • [10] Role of low-density lipoprotein apheresis
    Ziajka, P
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (4A): : 67E - 69E
12345